VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema
Young‐sup Yoon(Emory University), Douglas W. Losordo(Northwestern University), Edwin C. Gravereaux(Center for Vascular Biology Research), Toshinori Murayama(Northwestern University), David G. Jackson(John Radcliffe Hospital), Marianne Kearney(Northwestern University), Rudolf Kirchmair(Center for Vascular Biology Research), Andrea Wecker(Center for Vascular Biology Research), Tengiz Tkebuchava(Center for Vascular Biology Research), Hajime Kubo(University of Helsinki), Marcy Silver(Center for Vascular Biology Research), Jeffrey M. Isner(Tufts University), Cynthia J. Curry(University Medical Center Groningen), Alan B. Ashare(Tufts University), Chunsong Hu(Nanchang University)
Cited by 262
Related Papers
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
|Journal of Clinical Investigation|1998|1.2k
Gene Therapy for Myocardial Angiogenesis
|Circulation|1998|993
Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
|Journal of Clinical Investigation|1999|770
Intramyocardial Transplantation of Autologous CD34 <sup>+</sup> Stem Cells for Intractable Angina
|Circulation|2007|557
Diagnostic criteria for Walker‐Warburg syndrome
|American Journal of Medical Genetics|1989|448